Literature DB >> 3719054

A note on Shirley's nonparametric test for comparing several dose levels with a zero-dose control.

D A Williams.   

Abstract

Shirley (1977, Biometrics 33, 386-389) proposed a nonparametric version of Williams' test for determining the lowest dose level at which there is evidence of a toxic effect. A modification of Shirley's procedure is now proposed, which improves its power.

Mesh：

Year:  1986        PMID： 3719054

Source DB:  PubMed          Journal:  Biometrics        ISSN： 0006-341X            Impact factor:   2.571


  30 in total

1.  Relation between colour vision loss and occupational styrene exposure level.

Authors:  Y Y Gong; R Kishi; Y Katakura; E Tsukishima; K Fujiwara; S Kasai; T Satoh; F Sata; T Kawai
Journal:  Occup Environ Med       Date:  2002-12       Impact factor: 4.402

2.  Nonparametric bayes testing of changes in a response distribution with an ordinal predictor.

Authors:  Michael L Pennell; David B Dunson
Journal:  Biometrics       Date:  2007-08-30       Impact factor: 2.571

3.  Determination of the di-(2-ethylhexyl) phthalate NOAEL for reproductive development in the rat: importance of the retention of extra animals to adulthood.

Authors:  Chad R Blystone; Grace E Kissling; Jack B Bishop; Robert E Chapin; Gary W Wolfe; Paul M D Foster
Journal:  Toxicol Sci       Date:  2010-05-19       Impact factor: 4.849

4.  Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury.

Authors:  Hiroyuki Seki; Sadatomo Tasaka; Koichi Fukunaga; Yoshiki Shiraishi; Kiyoshi Moriyama; Keisuke Miyamoto; Yasushi Nakano; Naoko Matsunaga; Katsunori Takashima; Tatsumi Matsumoto; Masayuki Ii; Akitoshi Ishizaka; Junzo Takeda
Journal:  Inflamm Res       Date:  2010-04-13       Impact factor: 4.575

5.  Embryo-fetal development studies with the dietary supplement vinpocetine in the rat and rabbit.

Authors:  Natasha Catlin; Suramya Waidyanatha; Eve Mylchreest; Lutfiya Miller-Pinsler; Helen Cunny; Paul Foster; Vicki Sutherland; Barry McIntyre
Journal:  Birth Defects Res       Date:  2018-02-19       Impact factor: 2.344

6.  Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract.

Authors:  Natasha P Clayton; Katsuhiko Yoshizawa; Grace E Kissling; Leo T Burka; Po-Chuen Chan; Abraham Nyska
Journal:  Exp Toxicol Pathol       Date:  2006-10-23

7.  Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication.

Authors:  George W Koszalka; Nelson W Johnson; Steven S Good; Leslie Boyd; Stanley C Chamberlain; Leroy B Townsend; John C Drach; Karen K Biron
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions.

Authors:  M Shiomi; S Yamada; Y Amano; T Nishimoto; T Ito
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

9.  Pulmonary lesions in female Harlan Sprague-Dawley rats following two-year oral treatment with dioxin-like compounds.

Authors:  Nigel J Walker; Katsuhiko Yoshizawa; Rodney A Miller; Amy E Brix; Donald M Sells; Micheal P Jokinen; Michael E Wyde; Michael Easterling; Abraham Nyska
Journal:  Toxicol Pathol       Date:  2007-12       Impact factor: 1.902

10.  Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure.

Authors:  Matthew D Stout; Ronald A Herbert; Grace E Kissling; Bradley J Collins; Gregory S Travlos; Kristine L Witt; Ronald L Melnick; Kamal M Abdo; David E Malarkey; Michelle J Hooth
Journal:  Environ Health Perspect       Date:  2008-12-31       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.